ACTRN12605000247673已完成4 期
Prevention or delay of onset of psychosis in an 'ultra high risk' group: A comparison of risperidone and placebo in combination with intensive psychological treatment
Janssen-Cilag Pharmaceuticals0 个研究点目标入组 119 人开始时间: 2005年8月31日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 119
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 14 Years 至 30 Years（—）
- 性别
- All
入选标准
- •Participants must meet 'ultra high risk' criteria as outlined in Yung, Phillips and McGorry (2004) Treating Schizophrenia in the Prodromal Phase. London: Taylor nd Francis. Also, have not previously experienced psychotic episode, IQ > 70, adequate English skills, and living in Melbourne metro area.
排除标准
- •No exclusion criteria
研究者
相似试验
已完成
不适用
Primary prevention of psychosis through interventions in the prodromal phaseISRCTN20328848Stavanger University Hospital (Norway)240
已完成
不适用
The prevention of psychosis in at risk mental stateMental disorderISRCTN21353122The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)240
已完成
不适用
Prevention of psychosis with a cognitive behavioural intervention in help-seeking young people with an at risk mental state for developing psychosisNL-OMON31359Parnassia (Den Haag)240
招募中
3 期
Multimodal Prevention of First Psychotic Episode – a 2x2-Factorial Randomized Trialinvestigating the efficacy of N-Acetylcysteine (NAC) and Integrated Preventive PsychologicalIntervention (IPPI) in Subjects Clinically at High Risk for PsychosisSubjects presenting ultra-high risk (UHR) for psychosis (e.g. attenuated psychotic symptoms, brief limited intermittend psychotic symptoms or a genetic risk in combination with a decline in social functioning)DRKS00010952Zentralinstitut für seelische Gesundheit/Central Institute of Mental Health (ZI)200
进行中（未招募）
1 期
Multimodal Prevention of First Psychotic Episode – a 2x2-Factorial Randomized Trial investigating the efficacy of Acetylcysteine (ACC) and Integrated Preventive Psychological Intervention (IPPI) in Subjects Clinically at High Risk for PsychosisEUCTR2014-003076-22-DECentral Institute of Mental Health Mannheim (ZI)130